Analysis of the role of v-rel in transcriptional regulation of high mobility group 14.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Oncogene

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8700510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of the carboxy terminus of v-Rel in transformation and activation of endogenous gene expression.

  1995cited by this paper
• v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development

  1995cited by this paper
• Incorporation of chromosomal proteins HMG‐14/HMG‐17 into nascent nucleosomes induces an extended chromatin conformation and enhances the utilization of active transcription complexes.

  1995cited by this paper
• Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER.

  1995cited by this paper
• Function and activation of NF-kappa B in the immune system.

  1994cited by this paper
• The Rel family of proteins in oncogenesis and differentiation.

  1994cited by this paper
• Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors

  1994cited by this paper
• Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14.

  1994cited by this paper
• v-rel induces expression of three avian immunoregulatory surface receptors more efficiently than c-rel

  1994cited by this paper
• In vivo evolution of c-rel oncogenic potential

  1994cited by this paper
• Aberrant expression of high mobility group chromosomal protein 14 affects cellular differentiation.

  1993cited by this paper
• Differential expression of the chromosomal high mobility group proteins 14 and 17 during the onset of differentiation in mammalian osteoblasts and promyelocytic leukemia cells

  1993cited by this paper
• NF-kappa B subunit-specific regulation of the interleukin-8 promoter

  1993cited by this paper
• Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.

  1993cited by this paper
• Deposition of chromosomal protein HMG‐17 during replication affects the nucleosomal ladder and transcriptional potential of nascent chromatin.

  1993cited by this paper
• Promoter analysis of the gene encoding the I kappa B‐alpha/MAD3 inhibitor of NF‐kappa B: positive regulation by members of the rel/NF‐kappa B family.

  1993cited by this paper
• NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

  1993cited by this paper
• Cytokine‐inducible expression in endothelial cells of an I kappa B alpha‐like gene is regulated by NF kappa B.

  1993cited by this paper
• Role of rel family genes in normal and malignant lymphoid cell growth.

  1992cited by this paper
• The Rel family: models for transcriptional regulation and oncogenic transformation.

  1992cited by this paper
• Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.

  1992cited by this paper
• Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel

  1992cited by this paper
• The characterization of the promoter of the gene encoding the p50 subunit of NF‐kappa B indicates that it participates in its own regulation.

  1992cited by this paper
• Hormone‐regulated v‐rel estrogen receptor fusion protein: reversible induction of cell transformation and cellular gene expression.

  1992cited by this paper
• Interaction of the v-rel protein with an NF-kappa B DNA binding site.

  1991cited by this paper
• Oncogenic conversion by regulatory changes in transcription factors.

  1991cited by this paper
• Developmental changes in the expression of high mobility group chromosomal proteins.

  1991cited by this paper
• Recombinant human chromosomal proteins HMG-14 and HMG-17.

  1991cited by this paper
• Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65.

  1991cited by this paper
• A member of the set of kappa B binding proteins, HIVEN86A, is a product of the human c-rel proto-oncogene.

  1991cited by this paper
• B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50.

  1991cited by this paper
• Alterations at the rel locus in human lymphoma.

  1991cited by this paper
• Estrogen‐dependent alterations in differentiation state of myeloid cells caused by a v‐myb/estrogen receptor fusion protein.

  1991cited by this paper
• Malignant transformation by mutant Rel proteins.

  1991cited by this paper
• Expression of v-rel in a replication competent virus: transformation and biochemical characterization.

  1991cited by this paper
• Immunochemical analysis of the exposure of high mobility group protein 14 and 17 surfaces in chromatin.

  1990cited by this paper
• The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function.

  1990cited by this paper
• Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines.

  1990cited by this paper
• Characterization of a novel promoter insertion in the c-rel locus

  1990cited by this paper
• An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1990cited by this paper
• A single copy gene for chicken chromosomal protein HMG-14b has evolutionarily conserved features, has lost one of its introns and codes for a rapidly evolving protein.

  1990cited by this paper
• Structural features of the HMG chromosomal proteins and their genes.

  1990cited by this paper
• Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors

  1990cited by this paper
• NF-kappa B binds within a region required for B-cell-specific expression of major histocompatibility complex class II gene E alpha d

  1989cited by this paper
• NF‐kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation.

  1989cited by this paper
• Viral rel and cellular rel associate with cellular proteins in transformed and normal cells.

  1989cited by this paper
• The yeast STE12 protein binds to the DNA sequence mediating pheromone induction.

  1989cited by this paper
• The SV40 TC‐II(kappa B) and the related H‐2Kb enhansons exhibit different cell type specific and inducible proto‐enhancer activities, but the SV40 core sequence and the AP‐2 binding site have no enhanson properties.

  1989cited by this paper
• NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.

  1988cited by this paper
• Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.

  1988cited by this paper
• Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

  1986cited by this paper
• Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene

  1984cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Isolation of tha avian reticuloendothelial virus (strain T).

  1974cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Mutations in the v-Rel Transactivation Domain Indicate Altered Phosphorylation and Identify a Subset of NF-κB-Regulated Cell Death Inhibitors Important for v-Rel Transforming Activity

  2003cites this paper
• Oncogene rel Transformation Induced by the vAP-1 Factors Play an Important Role in

  1998cites this paper
• AP-1 Factors Play an Important Role in Transformation Induced by the v-rel Oncogene

  1998cites this paper
• Characterization of changes in gene expression associated with malignant transformation by the NF-κB family member, v-Rel

  1997cites this paper
• Jr antiapoptotic activity of the v-Rel oncoprotein . protein family , is a mediator of the ch-IAP 1 , a member of the inhibitor-of-apoptosis

  1997cites this paper
• ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein

  1997cites this paper
• Rel/NF-kappa B transcription factors and cancer.

  1997cites this paper